Sulfonyl urea drugs are usually tolerated by patients well. Side effects include:
- Severe drop in blood sugar.
Although sulfonylurea is less dangerous than insulin, it may cause a severe drop in blood sugar, but this severe drop in blood sugar from sulfoniluria may be prolonged and at the same time dangerous to the patient.
When you start using sulfonil urea, the risk of hypoglycemia is greater in the first few days and up to the first four months of use.
It is therefore important to emphasize that the patient should be aware of the level of sugar in the blood during this period.
It is also necessary to ensure the level of sugar in the blood continuously when practicing sports and increase activity or in the absence of taking the meal.
Patients should be alerted to the importance of eating breakfast, lunch and a snack before bedtime. Failure to eat or delay a meal can lead to a severe drop in blood sugar.
The risk of severe hypoglycemia from the use of second-generation sulfonylurea, such as glymaride, is equivalent to 1/10 that is updated by first-generation sulfonylurea.
- Weight gain causes increased appetite to eat and this is not desirable in obese patients with diabetes.
- These drugs may occur redness of the face, especially when using chlorampramide with alcohol.
- Chlorobramide can cause water retention in the body.
It is similar in effect to the hormone Vasopressin inhibitor for urination.
This leads to low blood sodium level and the occurrence of water poisoning.
- Occurrence of septicemia is rare and may occur in less than 1% of patients.
- These drugs can cause a slight risk to the heart.
- Nausea and metallic taste or change in taste in 1-3% of patients.
The drugs that compete with the centers of the association of sulfonyl urea drugs with blood proteins, or drugs that affect their metabolism in the liver can interact with sulfonylurea drugs and increase or Resists its anti-sugar effect.
- Severe drop in blood sugar.
Although sulfonylurea is less dangerous than insulin, it may cause a severe drop in blood sugar, but this severe drop in blood sugar from sulfoniluria may be prolonged and at the same time dangerous to the patient.
When you start using sulfonil urea, the risk of hypoglycemia is greater in the first few days and up to the first four months of use.
It is therefore important to emphasize that the patient should be aware of the level of sugar in the blood during this period.
It is also necessary to ensure the level of sugar in the blood continuously when practicing sports and increase activity or in the absence of taking the meal.
Patients should be alerted to the importance of eating breakfast, lunch and a snack before bedtime. Failure to eat or delay a meal can lead to a severe drop in blood sugar.
The risk of severe hypoglycemia from the use of second-generation sulfonylurea, such as glymaride, is equivalent to 1/10 that is updated by first-generation sulfonylurea.
- Weight gain causes increased appetite to eat and this is not desirable in obese patients with diabetes.
- These drugs may occur redness of the face, especially when using chlorampramide with alcohol.
- Chlorobramide can cause water retention in the body.
It is similar in effect to the hormone Vasopressin inhibitor for urination.
This leads to low blood sodium level and the occurrence of water poisoning.
- Occurrence of septicemia is rare and may occur in less than 1% of patients.
- These drugs can cause a slight risk to the heart.
- Nausea and metallic taste or change in taste in 1-3% of patients.
The drugs that compete with the centers of the association of sulfonyl urea drugs with blood proteins, or drugs that affect their metabolism in the liver can interact with sulfonylurea drugs and increase or Resists its anti-sugar effect.
Labels
SULFONYL UREA DRUGS